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Background: Although progress has been made in the treatment of articular cartilage lesions, they are still a major
challenge because current techniques do not provide satisfactory long-term outcomes. Tissue engineering and the
use of functional biomaterials might be an alternative regenerative strategy and fulfill clinical needs. Decellularized
extracellular matrices have generated interest as functional biologic scaffolds, but there are few studies on cartilage
regeneration. The aim of this study was to evaluate in vitro the biological influence of a newly developed
decellularized human dermal extracellular matrix on two human primary cultures.
Methods: Normal human articular chondrocytes (NHAC-kn) and human mesenchymal stromal cells (hMSC) from
healthy donors were seeded in polystyrene wells as controls (CTR), and on decellularized human dermis batches
(HDM_derm) for 7 and 14 days. Cellular proliferation and differentiation, and anabolic and catabolic synthetic
activity were quantified at each experimental time. Histology and scanning electron microscopy were used to
evaluate morphology and ultrastructure.
Results: Both cell cultures had a similar proliferation rate that increased significantly (p < 0.0005) at 14 days. In
comparison with CTR, at 14 days NHAC-kn enhanced procollagen type II (CPII, p < 0.05) and aggrecan synthesis
(p < 0.0005), whereas hMSC significantly enhanced aggrecan synthesis (p < 0.0005) and transforming growth
factor-beta1 release (TGF-β1, p < 0.0005) at both experimental times. Neither inflammatory stimulus nor catabolic
activity induction was observed. By comparing data of the two primary cells, NHAC-kn synthesized significantly
more CPII than did hMSC at both experimental times (p < 0.005), whereas hMSC synthesized more aggrecan at
7 days (p < 0.005) and TGF-β1 at both experimental times than did NHAC-kn (p < 0.005).
Conclusions: The results obtained showed that in in vitro conditions HDM_derm behaves as a suitable scaffold for
the growth of both well-differentiated chondrocytes and undifferentiated mesenchymal cells, thus ensuring a
biocompatible and bioactive substrate. Further studies are mandatory to test the use of HDM_derm with tissue
engineering to assess its therapeutic and functional effectiveness in cartilage regeneration.
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Articular cartilage lesions following acute trauma or
pathological conditions such as osteonecrosis, osteochon-
dritis and rheumatoid arthritis are responsible for the
highest rate of disability worldwide [1]. These pathologies
represent a serious socio-economic problem for the patient
with regards to morbidity, gait abnormality, pain and
inability to return to work and for health systems due to
the high related costs. Present treatment methods do not
provide a satisfactory long-term outcome; an innovative
and widely investigated approach consists of grafting
scaffold alone or immature tissue to allow chondrogenesis
to occur in situ [2,3]. Functional biomaterials for cartilage
regeneration should ideally provide (1) specific biomimetic
hierarchical structures that might result in the formation
of hyaline cartilage; (2) mechanical compatibility that could
maintain original biomaterial morphology under repetitive
physiological loads; (3) release of biosignals to promote
chondrogenesis differentiation; and (4) enhanced inte-
gration properties with host tissues, thus allowing host
cell infiltration and ideally even enhance the biology of
healing [4].
Xenogenic and allogenic decellularized extracellular
matrices (ECMs) have aroused great interest as functional
biologic scaffolds also in cartilage tissue regeration [1,5].
ECMs elicit distinct host-tissue histological and morpho-
logic responses, depending on the species of origin, tissue
of origin, processing methods, and/or method of terminal
sterilization [6]. They provide a compromise between
biomechanical and biological function for the healing
process, modulating host cell response and, consequently,
accelerating the biology of tissue repair and integration with
adjacent cartilage [6,7].
To the authors’ knowledge, there are few studies that as-
sess the biological properties of acellular ECM membranes
as scaffolds for cartilage tissue engineering and regenerative
medicine, not only in terms of proliferation and viability,
but also anabolic and catabolic synthetic activity [8-13].
Yang Q et al. and Yang Z et al. developed a natural acellular
3D interconnected porous scaffold which resulted in a
valid support for the attachment, proliferation and dif-
ferentiation of bone marrow mesenchymal stromal cells
into chondrocytes. Gong et al. proposed a sandwich
model of an acellular cartilage sheet for in vitro and
in vivo cartilage engineering, thus mimicking the native
environment and the structure of cartilage. Finally, a
previous study by the current authors on the behaviour
of a decellularized human dermis (HDM_derm), cul-
tured with primary rat tenocytes, showed in vitro a high
biological performance and mechanical competence of
HDM_derm [14].
The aim of the present study was to evaluate in vitro the
biological influence of this newly developed decellularized
human dermal ECM on two human primary cultures -normal human articular chondrocytes (NHAC-kn) derived
from knee articular cartilage, which represents the mature
phenotype of hyaline articular cartilage, and human mesen-
chymal stromal cells (hMSC) derived from bone marrow.
Methods
Decellularization of human dermis
Decellularized human dermis (HDM_derm) was taken
from the back of four multi-organ and/or multi-tissue
donors by following strictly Directive 2004/23/EC and
Italian Transplant Center Guidelines on harvesting,
processing and distributing tissues for transplantation.
In sterile conditions, using an electric dermatome, the
epidermis was separated from the dermis trunk area and
dermis samples of about 10 cm2 were dissected. The thick-
ness of the dermal samples was about 0.8 mm. The dermis
grafts were rinsed with 0.9% NaCl solution and stored
in this solution for transport (2-4°C) to the treatment
station (< 12 hrs) where they were submitted aseptically
to a combined treatment of decellularization. The tissue
was treated with 2.5% trypsin (GIBCO, catalogue n.
15090) and placed in an incubator overnight (5% CO2 at
37°C), washed twice with sterile 0.9% NaCl to remove
trypsin remnants, then dipped in RPMI medium
(containing 10000 IU/ml penicillin, 10 mg/ml strepto-
mycin, 25 μg/ml amphotericin B) for 15 minutes and sealed
inside cryofreezing bags (Hemofreeze bag – DF 700–3 by
Fresenius Kabi) without adding cryoprotectors. Finally, the
dermis was submitted to irradiation with γ rays (100 Gy)
and stored in nitrogen vapour at -180/-190°C. This method
provides a decellularized ECM scaffold, as shown by
histology (H&E, DAPI stain), Transmission Electron
Microscopy, cell viability test and DNA amount (Picogreen
DNA Assay) [6].
Cell proliferation and biosynthesis on decellularized
human dermis
Normal human articular chondrocytes (NHAC-kn,
Clonetics™ Cell System, BioWhittaker Italia, Caravaggio,
Italy), derived from a single-donor knee articular cartilage,
and human mesenchymal stromal cells (Poietics™ hMSC,
Lonza Walkersville Inc., Walkersville, USA) harvested and
cultured from bone marrow of a single donor, were used
for the experiment. NHAC-kn and hMSC cells were
expanded using the Chondrocyte Growth Medium (CGM,
containing fetal bovine serum 5%, gentamicin sulphate-
amphotericin B 0.1%, b-Fibroblast Growth Factor 0.5%, R3-
Insulin-like Growth Factor-1 0.2%, insulin 0.2%, transferrin
0.1%) and the Mesenchymal Stem Cell Growth Medium
(MSCGM, containing 10% FCS, 30 μg/ml Gentamicin
and 15 ng/ml Amphotericin, Lonza Walkersville Inc.,
Walkersville, USA). Four different batches of HDM_derm
were aseptically cut into 10 × 10 mm2 pieces; NHAC-kn, at
passage 1, or hMSC were seeded onto forty-eight
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tration of NAHC-kn and hMSC cells was seeded in empty
polystyrene wells as control (CTR). After 24 h incubation,
of growth media were changed with Chondrocyte Differen-
tiation Medium (CDM, containing fetal bovine serum 5%,
gentamycin sulphate-amphotericin B 0.1%, Transforming
Growth Factor β-3 0.5%, R3- Insulin-like Growth Factor-1
0.2%, insulin 0.2%, transferrin 0.2%, and ascorbic acid 2.5%)
in NHAC-kn cultures and with Complete Chondrocyte
Induction Medium (Lonza Walkersville Inc., Walkersville,
USA) in hMSC cultures. After 24 h of incubation, the
medium was collected and non-adherent cells were
counted. Cell adhesion was calculated as the difference
between seeded cells and non-adherent cells, present in the
medium and attached to the 24-well plate bottom,
expressed as a percentage of the number of the seeded
cells. At 7 and 14 days, the supernatant was collected
and the following tests were performed: procollagen
type II C-propeptide (CPII ELISA, IBEX Technologies
Inc., Montreal, Quebec, Canada) and aggrecan (Human
Aggrecan EASIA™ ELISA kit, BioSource Europe SA,
Nivelles, Belgium) for phenotype expression, the multi-
functional peptide transforming growth factor- β1
(TGF-β1, quantikine human TGF-β1 immunoassay, R&D
Systems, MN, USA) for anabolic growth factor synthetic
activity, interleukin1β (IL-1β, quantikine human IL-1β im-
munoassay, R&D Systems, MN, USA) and matrix me-
talloprotease 3 (MMP3, quantikine human MMP3
immunoassay, R&D Systems, MN, USA) for inflammatory
and catabolic response assessment, respectively. The
measured protein concentrations were normalized by Total
Protein concentration (Total Protein Kit, Micro Lowry
method, Petterson’s Modification, SIGMAW, Missouri,
USA). The cell proliferation reagent WST-1 (Roche
Diagnostic GmbH, Penzberg, Germany) test was performed
and quantified spectrophotometrically at 450 nm with the
reference wavelength at 625 nm. Results were expressed as
% Vitality calculated as follows:
%Vitality ¼ 100  OD s
OD CTR
where ODs was the optical density of the sample and OD
CTR was the optical density of control wells.
Histology and scanning electron microscopy
After 14 days of cell culture, the seeded membranes were
studied to evaluate chondrocyte and mesenchymal stromal
cell colonization inside HDM_derm by histology and scan-
ning electron microscopy (SEM). For histology, specimens
were fixed in 10% buffered formalin solution in PBS
(pH 7.4), embedded in paraffin and sections were cut to
6-μm thickness and stained with Haematoxilin & Eosin,
Safranin O and Alcian Blue. Images were grabbed by usingan Olympus BX51 microscope equipped with XC30
Olympus camera. For SEM, specimens were fixed in
2.5% v/v glutaraldehyde (pH 7.4 in PBS 0.01M, 1h) and
dehydrated in graded ethanol series. After a passage in
hexamethyldisilazane, the samples were air dried, then
sputter-coated with gold before being examined by a
Philips XL-20 SEM.
Statistical analysis
Statistical evaluation of data was performed using the
SPSS/PC+ Statistics TM 12.1 (SPSS Inc., Chicago, IL USA)
software package. Data are reported as Mean ± SD at a
significance level of p < 0.05. After checking normal
distribution and homogeneity of variance, two-way
ANOVA (group and experimental time) followed by
Bonferroni’s t test were used to compare results. Student’s
t test was used to compare cell vitality index results.
Results
In vitro model
At 24 hours after seeding, cells adhered consistently to
HDM_derm membranes (93% and 98% for NHAC-kn
and hMSC, respectively). At 7 days, the cell vitality
index was 98% for both cell cultures seeded on
HDM_derm. After 14 days of culture, these indexes
significantly (p < 0.0005) increased for both cell cultures
(NHAC-kn 136%, hMSC 263%).
Tables 1 and 2 show the results of NHAC-kn and hMSC
cells seeded on the HDM_derm membrane at 7 and 14
days. The phenotypic expression given by the synthesis of
CPII did not differ within the two cell types. The synthesis
of CPII on HDM_derm increased between experimental
times for both cell types (NHAC-kn, p < 0.05; hMSC,
p < 0.05). At both experimental times, HDM_derm
induced NHAC-kn to produce almost double the amount
of CPII than did CTR (p < 0.05). The synthetic activity,
expressed by the measured concentration of aggrecan,
increased over time in both cells (p < 0.0005). NHAC-kn
(14 days) and hMSC (7 and 14 days) seeded onto
HDM_derm produced significantly higher amounts of
aggrecan than those seeded on CTR (p < 0.0005). Regard-
ing the synthesis and release of TGF-β1, significant
decreases were found for NAHC-kn (p < 0.05) and hMSC
(p < 0.0005) in the CTR group between experimental times.
For hMSC, significantly higher TGF-β1 values were found
when cultured on HDM_derm than those found on CTR
at both 7 and 14 days (p < 0.0005). Concerning inflamma-
tory responses, no statistically difference in the release of
IL-1β was observed for both cells and experimental times.
At 7 days NHAC-kn seeded onto HDM_derm produced
significantly lower values of MMP-3 compared with
CTR (p < 0.005). Furthermore, the MMP-3 released by
NHAC-kn in CTR was observed to decrease significantly
over the culture time (p < 0.005).
Table 1 In vitro results of NHAC-kn cultured on HDM_derm and CTR for 7 and 14 days
HDM_derm CTR Two-way ANOVA
7 days 14 days 7 days 14 days
CPII (pg/mg) 79.0 ± 13.5* 145.0 ± 21.2*,° 39.8 ± 13.8 71.0 ± 7.4 F=6.9, p < 0.05
Aggrecan (ng/mg) 490.8 ± 60.0 937.4 ± 76.2***,°°° 517.6 ± 32.8 583.4 ± 20.8 F=66.5, p < 0.0005
TGF-β1 (pg/mg) 2821.7 ± 145.7 2785.6 ± 405.1 3015.7 ± 125.6 2332.3 ± 89.4° F=10.2, p < 0.05
IL-1β (pg/mg) 0.8 ± 0.1 1.0 ± 0.2 0.8 ± 0.0 0.8 ± 0.0 NS
MMP3 (ng/mg) 5.8 ± 3.8** 3.3 ± 1.5 18.6 ± 1.7 5.8 ± 0.2°° F=16.7, p < 0.005
Bonferroni t test (Mean ± SD, n = 8 replicates):
- between HDM_derm and CTR within each experimental time: *, p<0.05; **, p<0.005; ***, p<0.0005.
- between experimental times within each tested membrane: °, p<0.05; °°, p<0.005; °°°, p<0.0005.
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tained from NHAC-kn and hMSC cultures seeded on
HDM_derm were normalized to those of their controls
(Table 3). When comparing normalized data, NHAC-kn
showed a significant increase in CPII synthesis with respect
to that showed by hMSC cells, approximately 2.2 fold,
at both experimental times (p < 0.005), whereas hMSC
cells induced a significant increase in aggrecan at 7 days
(1.6 fold, p < 0.005) and TGF-β1 at both experimental times
(approximately 1.5 fold at 7 days and 2.3 fold at 14 days)
compared with that induced by NHAC-kn cells (p < 0.005).Histology and Scanning Electron Microscopy (SEM)
The main histo-architecture of the acellular extracellular
matrix was retained. After 14 days in static culture, both
cells grew prevalently on the HDM_derm surface. NHAC
showed rounded features forming aggregates along the
HDM_derm surface and penetrating in the deeper layers
of the decellularized membrane (Figure 1a). hMSC exhib-
ited a fibroblast-like morphology with elongated nuclei
covering the membranes, whereas occasional cells were
observed to infiltrate more deeply (Figure 1b). Safranin O
(Figures 1c,d) and Alcian blue (Figures 1e,f) stainings
showed proteoglycan synthesis, only at intracellular level,
and the presence of GAGs deposited on the decellularized
matrix just in the proximity of grown cells, respectively,
without differences between NHAC-kn and hMSC.Table 2 In vitro results of hMSC cultured on HDM_derm and C
HDM_derm
7 days 14 days
CPII (pg/mg) 82.2 ± 1.5 136.8 ± 3.0°
Aggrecan (ng/mg) 191.7 ± 6.1*** 265.7 ± 7.4***, °°°
TGF-β1 (pg/mg) 926.9 ± 4.5*** 894.1 ± 18.9***
IL-1β (pg/mg) 0.5 ± 0.0 0.5 ± 0.1
MMP3 (ng/mg) 0.01 ± 0.01 0.18 ± 0.03
Bonferroni t test (Mean ± SD, n = 8 replicates):
- between HDM_derm and CTR within each experimental time: ***, p<0.0005.
- between experimental times within each tested membrane: °, p<0.05; °°°, p<0.000SEM analysis performed 14 days after seeding on HDM
showed different patterns for NHAC-kn and hMSC,
respectively. A homogeneous and multilayered surface-
covering colonization with possibly living cells was found
for NHAC-kn on HDM_derm: they had a polygonal-
rounded morphology or fusiform shape. Most of the cells
were connected to each other by forming cell aggregations
and were tightly interwoven within the collagen network.
Conversely, hMSCs partially covered HDM_derm by cell
aggregates associated with a clear-cut collagen meshwork
(Figure 1g,h).
Discussion
The aim of the present study was to assess the influence of
HDM_derm on two human primary cells – NHAC-kn and
hMSC −, in terms of CPII, aggrecan, TGF-β1, IL-1β and
MMP-3 release, in order to evaluate its possible use as a
scaffold for in situ tissue engineering techniques in cartilage
regenerative treatments. Human primary cells were chosen
because they provide conditions that closely simulate a
living model, thus yielding more physiologically significant
results than animal-derived cells or cell lines. Since it is
recognized that intra-species variability occurs, reproduci-
bility of results was checked by taking into consideration
dermis donor variability and not donor cell variability and
thus four different dermis donors were tested.
The current results showed that HDM_derm supported
NHAC-kn and hMSC cell adhesion, vitality, chondrogenicTR for 7 and 14 days
CTR Two-way ANOVA
7 days 14 days
90.9 ± 4.1 140.9 ± 2.6° F=4.86, p < 0.05
129.7 ± 3.5 184.0 ± 5.0°°° F=24.02, p < 0.0005
644.2 ± 23.1 324.1 ± 75.6°°° F=37.3, p < 0.0005
0.4 ± 0.0 0.6 ± 0.0 NS
Not detected Not detected NS
5.
Table 3 Normalized data of NHAC-kn and hMSC on HDM_derm to control at 7 and 14 days
Experimental time NHAC-kn hMSC
CPII/CPII CTR 7 days 2.02 ± 0.31** 0.90 ± 0.02
14 days 2.07 ± 0.28** 0.97 ± 0.02 °
Aggrecan/Aggrecan CTR 7 days 0.92 ± 0.12 1.48 ± 0.04**
14 days 1.58 ± 0.13°° 1.45 ± 0.03
TGF-β1/TGF-β1 CTR 7 days 0.95 ± 0.05 1.44 ± 0.01**
14 days 1.22 ± 0.17 ° 2.76 ± 0.06**,°°
Bonferroni t test (Mean ± SD, n = 8 replicates):
- between NHAC-kn and hMSC within each experimental time: **, p<0.005.
- between experimental times within each primary cell: °, p < 0.05; °°, p<0.005.
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cultures maintained their phenotype with significantly
increased synthesis of CPII and aggrecan, whereas the
hMSC cultures showed a significant increase in aggrecan
and TGF-β1 secretion. Furthermore, HDM-derm did not
induce the release of IL-1β and MMP-3 that are often used
as markers to measure inflammatory and catabolic stimuli
in vitro. The comparison between NHAC-kn and hMSC
normalized data revealed that, compared with hMSC,
NHAC-kn were able to increase CPII synthesis at both
experimental times, whereas hMSC were able to increase
aggrecan at 7 days and TGF-β1 at both experimental times
in comparison with NHAC-kn. In addition, the increased
production of TGF-β1 by hMSC cells over the control wells
may be responsible for the increased aggrecan synthesis via
autocrine and paracrine pathways, as also suggested by
other authors [15,16]. In the present authors’ opinion, the
differences observed between the cell-seeded construct and
empty polystyrene wells were due to several factors: (1)
stage of chondrogenic differentiation, NHAC-kn being
already phenotypically differentiated chondrocyte cells; (2)
the presence of a bioactive ECM membrane, as an environ-
mental condition that is recognized as being a key factor in
regulating cell behavior [17]; (3) the 3D-culture system con-
dition, that is known to affect chondrogenesis in particular.
The reason why HDM_derm retained bioactivity upon
decellularization might be because it participates and
directly enhances cellular adhesion and proliferation
indexes as found with NHAC-kn and hMSC, at least in
the early stages of culture. Some authors found dif-
ferences among growth factors (GFs) such as VEGF,
FGF and TGF-β release in the extraction vehicle from
different decellularized membranes [5,18,19]. Some
TGF-β1 activity was still detected in the extract of the
tested decellularized HDM_derm (428.36 ± 58.89 pg/mg)
almost at the same concentration as the non-decellularized
HDM_derm (417.01 ± 146.16 pg/mg), suggesting that
HDM_derm is a bioactive substrate [6]. In the present
authors’ opinion, the native retained TGF-β1 is released
from decellularized samples in a short culture time (within
6 days), thus affecting cell adhesion and early proliferation[5,6,8,20]. After that, it might be assumed that the anabolic
action of native TGF-β1 is almost completely exhausted by
replacing medium twice a week and degradation processes,
due to its finite lifespan.
Histological and SEM investigations supported in vitro
data and showed that the HDM_derm was colonized by
both cell types. Safranin O staining showed proteoglycans
mainly at intracellular level and partially just around
cells in both cultures, whereas Alcian Blue staining indi-
cated glycosaminoglycan deposition at extracellular
levels. These findings may suggest that, although GAGs
have already been secreted by both primary cells, the
macromolecules of proteoglycans, consisting of a core
protein on which numerous GAG chains are attached,
have yet to be assembled.
The experimental set up of the study had some weak-
nesses. First of all, the lack of a more clinically relevant
matrix as a control was a major limitation. The ideal
control material for the present study would be a dermis
from the same donors decellularized by an already
developed and recognized procedure. Unfortunately,
these decellularization techniques that are used in the
production of clinically accepted products are patented
and it was not possible to reproduce this technique on
the dermis derived from the donors included in the
present study. Therefore, it was preferred to perform
experiments without using other materials with different
chemical and physical properties such as synthetic scaffolds
or hydrogels.
The use of single-cell seeding density and relatively short
culture time was the second weaknesses of the current
experimental set up. Therefore, the seeding of HDM_derm
probably needed an improvement in the in vitro culture
conditions. In further in vitro experiments, the amount of
cells seeded on the scaffold should be addressed, to try and
increase the number up to 106 or 107 cells/ml, in order to
study the influence of cell concentration on improving the
building of a cartilage construct. However, the choice of cell
density and experimental times was made to prevent
irreversible contact-inhibition and senescence processes
that affect NHAC-kn cell controls especially and in light of
Figure 1 Histology and SEM patterns of NHAC-kn and hMSC seeded on HDM_derm at 14 days. Histological and SEM images of NHAC-kn
(a,c,e,g) and hMSC (b,d,f,h). The NHAC-kn and hMSC cells are qualitatively recognizable in HDM_derm. Haematoxilin & Eosin staining (a,b),
magnification of 40x (scale bar = 20 μm): both cell types grew superficially and deeply colonized the HDM_derm. Safranin O staining (c,d),
magnification of 80x (scale bar = 10 μm): presence of proteoglycan synthesis (dark red), predominantly inside cells and equally present in both
primary cells. Alcian blue staining (e,f), magnification of 80x (scale bar = 10 μm): around both primary cells light blue stain indicated the presence
of GAGs deposited on the decellularized matrix. SEM images show a complete colonization of HDM_derm scaffold by NHAC-kn with collagen
network still visible; NHAC-kn retained their viable morphology and cell-to-cell relationship (g). Sparse distribution of the few hMSC cell
aggregates is present (h).
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cultures of rat tenocytes seeded onto HDM_derm [14].
A further improvement in the current study set up might
be to adopt a dynamic standardized culture condition by
using bioreactors able to ensure efficient cell seeding,
colonizing the scaffold deeply and also able to reproduce a
mechanical stimulus to improve the cartilage-construct
differentiation and maturation as well as regulate micro-
environmental key factors in promoting chondrogenesis,
such as oxygen concentration and pressure, or the presence
of proteases [17,21].
Finally, the strengths of the current study were: (1) the
use of a new decellularization method on allogenic human
dermis that provided a reliable 3D structural and biological
scaffold for chondrocytes and MSCs; (2) the use of primary
non-transformed human cells that closely simulate a living
model, thus yielding more physiologically significant results
than animal derived cells.
Various in vitro studies have been performed with
different kinds of scaffolds with chondrocytes or MSCs
for cartilage regeneration and most of them employed
synthetic, biological or composite biomaterials such as
poly-(lactic-co-glycolic acid) (PLGA), poly (lactic acid)
PLA, poly (glycolic acid) PGA, hydrogel, chondroitin
sulphate, hyaluronic acid, collagen, agarose, alginate,
chitosan, gelatine, fibroin, fibrin glue or hybrid PLGA-
gelatin/chondroitin sulphate/hyaluronic acid as cell
supports [22-36].
Over the last few years, decellularized xenogenic and
allogenic ECMs have started to be investigated for cartilage
tissue engineering, because they retain structural and func-
tional proteins and antibacterial activity, which has been
shown within degradation products of biological scaffolds
composed of extracellular matrix [37]. However, the few
studies testing ECMs, such as bovine cartilage [10], porcine
adipose tissue [8], or cartilage [11,13], human adipose tissue
[12], or cartilage [9,13], investigating mainly the behaviour
of chondrocytes or MSCs in terms of proliferation and
viability, concluded that ECMs provided suitable 3D
substrates not only for the growth of cells, but also for
promoting the formation of new cartilaginous engineered
tissue. To our knowledge, the current study is the first to
address the use of human decellularized ECM as an alter-
native 3D scaffold for cartilage regeneration. By comparing
the present results to previously cited literature [8-13], it is
evident that inflammatory stimuli, and anabolic and cata-
bolic synthetic activity are not deeply investigated biological
aspects to evaluate a possible influence of ECM on chon-
drocyte or MSC behaviour. The decellularization technique
employed for the present scaffold did not adversely affect
the structural integrity and biological activity of the
remaining ECM of HDM_derm, thus its mechanical
competence was maintained [6,14]. The advantage of the
technique, consisting of a combination of trypsin washesand the extremely low dosage of gamma-ray irradiation
(about 0.1 kGy), is to avoid the use of strong chemical
agents, which might lead to toxic leachables in the decellu-
larized products, and the terminal sterilization process,
which are known to be the main causes of distinct host
tissue histological and morphologic responses [6,14].
Further in vitro studies are mandatory to test the use of
HDM_derm with tissue engineering techniques. The
present study on the possible application of HDM_derm
for cartilage suggests that this derived matrix might be
investigated also as a functional scaffold for chondrocyte re-
population for in situ engineering techniques. HDM_derm
seems to be a suitable matrix for cartilage regeneration,
because it has been shown by the present study to maintain
cellular viability and differentiation, and to retain structure
and bioactivity, particularly TGF-β1 that might counteract
catabolic IL-1β effects, whose levels have been found to
correlate with the severity of cartilage damage in vivo.
Finally, all in vitro data need to be transferred in vivo into
specific preclinical validated models of acute, chronic or
degenerative cartilage lesions to assess the therapeutic and
functional effectiveness of HDM_derm in cartilage repair
or regeneration.
Conclusions
In summary, to the present authors’ knowledge, this study
is the first piece of evidence to support the potential use of
human decellularized dermal matrix as a scaffold for car-
tilage regeneration. The results showed that the developed
HDM_derm might be used as a scaffold by acting as a bio-
logical and bioactive substrate for cell seeding, prolifera-
tion and synthetic activity. HDM_derm sustained the
growth and colonization of a well-differentiated pheno-
type NHAC-kn as well as undifferentiated hMSCs.
These results support the use of HDM_derm for further
preclinical in vitro and in vivo models for cartilage
tissue engineering.
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